{"grounding": "Apoptosis is central for the maintenance of health. In the immune system, apoptosis guarantees proper development of immune cells and shutdown of immune reactions by the coordinated elimination of activated immune cells. Limitation of the life span of granulocytes is important, as overactivation of these cells is associated with chronic inflammation and collateral tissue damage. Consequently, targeted induction of granulocyte apoptosis may be beneficial in the course of respective immune disorders. Anti-inflammatory drugs such as glucocorticoids and monoclonal antibodies against IL-5R\u03b1 exert their function in part by triggering eosinophil apoptosis. Agonistic antibodies targeting Siglec-8 or death receptors are tested (pre)clinically. Moreover, a new class of inhibitors targeting antiapoptotic BCL-2 proteins shows great promise for anticancer treatments. Because of their specificity and tolerable side effects, these so-called BH3 mimetics may be worthwhile to evaluate in inflammatory disorders. Here, we review past and recent data on pharmacological apoptosis induction of granulocytes and highlight respective therapeutic potential.", "generated_text": "The pharmacological induction of granulocyte cell death presents a promising therapeutic strategy for managing diseases characterized by excessive or dysfunctional granulocyte activity. Granulocytes, including neutrophils, eosinophils, and basophils, play crucial roles in the immune response but can contribute to pathological conditions when dysregulated. This study explores the mechanisms of apoptosis in granulocytes and evaluates potential pharmacological agents that selectively induce cell death in these immune cells. By targeting specific pathways involved in granulocyte survival and apoptosis, such as the Bcl-2 family proteins and caspase activation, it is possible to modulate the immune response and alleviate symptoms in conditions like asthma, chronic obstructive pulmonary disease, and autoimmune disorders. Additionally, the impact of these agents on lymphocytes is considered to ensure minimal off-target effects. The findings suggest that selective induction of granulocyte apoptosis could be a viable approach to restoring immune homeostasis and improving patient outcomes in granulocyte-mediated diseases.", "label": 1}